Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating expenses:
Net loss	$ (1,766,025)	$ (1,909,575)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,543	2,163
Interest expense related to amortization and acceleration of debt discount	(139)
Change in fair value of financial instruments	(80,352)	86,122
Stock-based compensation	508,265	157,551
Issuance of common stock for services		106,850
Bad debts expense	124,415	15,653
Cancellation of trade liabilities and unpaid interest	(102,128)	(239,250)
Changes in operating assets and liabilities:
Accounts receivable	(265,490)	(10,246)
Costs and estimated earnings in excess of billings on uncompleted contracts	29,978	(25,946)
Inventory	(48,011)	376,150
Prepaid expenses and other current assets	(1,405)	27,778
Accounts payable and accrued expenses	(33,069)	158,698
Accrued compensation and related costs		(66,422)
Accrued interest, related party	8,220	1,213
Accrued interest		(554)
Related party accounts payable and accrued expenses	83,753	(47,940)
Billings in excess of costs and estimated earnings on uncompleted contracts	69,789	(1,800)
Deferred revenue	201,117	(221,951)
Net cash used in operating activities	(1,268,539)	(1,591,506)
Cash flows used in investing activities
Purchase of short-term investment		(39,110)
Purchase of equipment	(549)	(5,809)
Cash acquired from reverse merger		770
Net cash used in investing activities	(549)	(44,149)
Cash flows from financing activities:
Expenditures on debt issuance costs	(140,466)
Principal payments on short-term notes payable		(41,247)
Proceeds from issuances of common stock	74,250	1,200,000
Proceeds from issuance of common stock and warrants in private offering	642,183
Proceeds from issuance of convertible debentures	1,000,000
Net cash provided by financing activities	1,575,967	1,158,753
Effect of exchange rate changes in cash	(571)
Net increase (decrease) in cash	306,308	(476,902)
Cash and cash equivalents - beginning of year	561,759	1,038,661
Cash and cash equivalents - end of year	868,067	561,759
Cash paid during the year/period for:
Interest		2,520
Supplemental disclosure of non-cash financing activities:
In connection with the private offering, $80,000 was paid for a prior liabilitywhich was included in accounts payable and accrued expenses.	67,782	10,000
Issuance of common stock for settlement of debt	67,782	10,000
Forgiveness of related party accrued compensation	73,888
In connection with the reverse merger dated November 4, 2011, the Company acquired the following liabilities:
Accounts payable and accrued expenses		105,834
Accrued interest, related party		11,006
Related party notes payable		$ 73,500